These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32339444)

  • 1. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
    Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
    Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.
    Ahuja S; Malviya A
    Cytopathology; 2022 Mar; 33(2):176-184. PubMed ID: 34913541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.
    Rajeswaran PK; Srinivasan V; Mahesh SSV; Ashok AU
    Acta Cytol; 2023; 67(1):70-79. PubMed ID: 36476509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
    Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z
    Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.
    Straccia P; Chiappetta M; Magnini D; Cancellieri A
    Cytopathology; 2022 May; 33(3):305-311. PubMed ID: 35213747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.
    Wang M; Sun T; Jiao J; Wang H
    Cancer Cytopathol; 2023 Jul; 131(7):433-441. PubMed ID: 36973963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.
    Lu CH; Liu CY; Jhuang JY; Chen CC
    Cancer Cytopathol; 2024 Mar; 132(3):169-178. PubMed ID: 38062987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the newly published International System for Reporting Serous Fluid Cytopathology in atypical and suspicious diagnosis: a four-year retrospective analysis.
    Shen Y; Gosnell JM; Nawgiri R; Muthukumarana V
    J Am Soc Cytopathol; 2024; 13(4):303-308. PubMed ID: 38637263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies.
    Sun T; Wang M; Wang H
    Cancer Cytopathol; 2022 Dec; 130(12):964-973. PubMed ID: 35994357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.
    Sachan R; Gupta A; Awasthi PN; Singh P; Anand N; Chandra S; Gaur G; Husain N; Sachan KD
    J Am Soc Cytopathol; 2023; 12(5):351-361. PubMed ID: 37244848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology.
    Xu Y; Hu AY; Wang SM; Wang Q; Pan YC; Zhang SH
    Diagn Cytopathol; 2021 Sep; 49(9):997-1007. PubMed ID: 34019334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.
    Zhu YL; Ren WH; Wang Q; Jin HZ; Guo YY; Lin DM
    Diagn Pathol; 2022 Jul; 17(1):56. PubMed ID: 35780135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of International System for Reporting Serous Fluid Cytopathology: A systematic review and meta-analysis in malignancy diagnosis.
    Ahuja S; Ahuja R; Pandey S; Zaheer S
    Cancer Cytopathol; 2024 Oct; 132(10):609-620. PubMed ID: 38613789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: A retrospective study.
    Yang H; Zhu J; Wang P
    Medicine (Baltimore); 2023 Oct; 102(43):e35707. PubMed ID: 37904355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering Serous Effusions Using the New International System for Reporting Serous Fluid Cytopathology.
    Mandava H; Venkata Renuka I; Potti R; Mounica B; Kalla I
    Cureus; 2024 May; 16(5):e60042. PubMed ID: 38774462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Malignancy in Effusions according to the International System for Serous Fluid Cytopathology: A Review.
    Castilho da Silva DJ; Dos Santos CR; Xavier-Júnior JCC
    Acta Cytol; 2024; 68(4):384-393. PubMed ID: 39025059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Categorisation of peritoneal serous effusions using the International System for Reporting Serous Fluid Cytopathology-A study on gynaecological samples.
    Rakheja G; Singh M; Priyadarshnee B; Marimuthu B; Dhar L; Jain S; Khurana N; Rathore A
    Cytopathology; 2023 Mar; 34(2):138-145. PubMed ID: 36530023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.
    Jha S; Sethy M; Adhya AK
    Diagn Cytopathol; 2021 Oct; 49(10):1089-1098. PubMed ID: 34289263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Novel Tiered Reporting System in Serous Fluid Cytology and Risk of Malignancy Assessment: A Retrospective Study in a Tertiary Care Center.
    Alashetty S; Sadasivan B; Dharmalingam P; Rajagopal N; Kavya L; Pai MM
    J Cytol; 2023; 40(3):107-113. PubMed ID: 37745807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions.
    Hou T; Landon G; Stewart J; Roy-Chowdhuri S
    Cancer Cytopathol; 2021 Jan; 129(1):75-82. PubMed ID: 32809259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.